Flora (microbiology)

Danone North America Celebrates a Decade of Commitment to Exploring Impact of Gut Microbiome on Human Health

Retrieved on: 
Tuesday, May 17, 2022
Probiotic, Education, Cornell University, Yogurt, Doctor of Philosophy, Food, Breast milk, Agriculture, Science, Investment, Multimedia, Social behavior, Research, Grant (money), Brain, Intention, Female, University of California, Riverside, RNA, University, Faculty, Ecosystem, Bureau of Oceans and International Environmental and Scientific Affairs, Immune system, Flora (microbiology), Growth, Male, Randy Nteka, WhiteWave Foods, Dietary supplement, Health, Danone

WHITE PLAINS, N.Y., May 17, 2022 /PRNewswire/ -- Danone North America continues to show its commitment to furthering research, science, and education in the field of the Gut Microbiome, Yogurt and Probiotics through their Fellowship Grant Program. The 2021-2022 program marks ten years and half a million dollars' worth of grants awarded to empower creative minds and nurture scientific advances. This year's esteemed honorees, selected by a committee of scientific experts, are Elena Kozlova at University of California, Riverside and Yannis Ntekas at Cornell University.

Key Points: 
  • "Danone North America has an unwavering commitment to funding research that helps us better understand how to maintain and improve health.
  • Both Elena Kozlova and Yannis Ntekas are poised to conduct successful studies and have impactful careers that will contribute to scientific discoveries and expand our understanding of probiotics, the gut microbiome, and human health."
  • The Danone Fellowship Grant was established in 2010 with the intention of providing funding for novel studies of yogurt, probiotics, and the gut microbiome.
  • Winners were chosen based on the quality of their proposals, faculty recommendations, and each of their studies' value to human health and wellness.

The Global Lactoferrin Market Expected to Expand at a CAGR of 8.2% from 2021 to 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, February 18, 2022
Health, Other Health, Energy drink, Nursing care plan, Cosmetics, Flora (microbiology), Tissue, Fungus, Asia-Pacific, Immune system, Awareness, Acne, Milk, Virus, Cell, Probiotic, Infant, Culture, Chemistry (relationship), Bacteria, USD, Ageing, Lactoferrin, Food, Acquisition, Nose, Infant formula, Growth, Anemia, Inflammation, Research, CAGR, Dietary supplement

The global lactoferrin market is expected to reach USD 411.8 million by 2028.

Key Points: 
  • The global lactoferrin market is expected to reach USD 411.8 million by 2028.
  • It is expected to expand at a CAGR of 8.2% from 2021 to 2028.
  • Lactoferrin is found effective for the treatment of hepatitis C infection by inhibiting replication of the virus at the intracellular level.
  • Asia Pacific is expected to expand at a CAGR of over 7.5% during the forecast period.

VastBiome Announces Large Exploratory Prospective Data Collection to Understand Basic Science of the Microbiome and Immune Checkpoint Inhibitor Therapy

Retrieved on: 
Friday, January 14, 2022
Medical Devices, FDA, Hospitals, Clinical Trials, Biotechnology, Other Health, Health, Pharmaceutical, General Health, Triple-negative breast cancer, Patient, Synthetic biology, Flora (microbiology), Pursuit, ICI, Probiotic, Collection, CEO, Melanoma, Gastrointestinal tract, Bacteria, Artificial intelligence, Renal cell carcinoma, Cancer, Immune system, Blood, Large-cell lung carcinoma, Pharmaceutical industry, Immunotherapy

VastBiome is announcing sponsorship of an observational clinical study designed to collect data to understand molecular associations between immune checkpoint inhibitor (ICI) therapy and the gut microbiome (the collection of bacteria and other bugs living in the gastrointestinal tract).

Key Points: 
  • VastBiome is announcing sponsorship of an observational clinical study designed to collect data to understand molecular associations between immune checkpoint inhibitor (ICI) therapy and the gut microbiome (the collection of bacteria and other bugs living in the gastrointestinal tract).
  • This study, named PARADIGM (Pursuit to Analyze and Reveal Associated Drivers of Immunotherapy outcomes through the Gut Microbiome) is listed on ClinicalTrials.gov (NCT05037825) and actively enrolling patients.
  • PARADIGM will monitor patients immune system and microbiome across multiple cycles of ICI therapy and its findings may offer new insights into the microbiomes role in cancer and its effects on the host immune system.
  • VastBiome, is a drug discovery company mining the gut microbiome for small molecules to treat immunological disorders and advance immunotherapy.

Amlan International to Present New Research During International Production and Processing Expo (IPPE)

Retrieved on: 
Thursday, January 13, 2022
Research, DVM, National university, Flora (microbiology), NYSE, Homeostasis, IPPE, Efficiency, Marketing, Laboratory, Technology, Universidad, Southern International Productions, Congress Center, Wall, IPSF, Doctor of Philosophy, Poultry, Poultry Science Association, Health, Master of Science, TTSS, ODC, Mycotoxin, Livestock, III, Mallmann, 2021 Essex County Council election, Georgia World Congress Center, Government, University of Arkansas, GLOBE, M52, Miniature pig, University, Feed manufacturing, International, Eimeria, Microbiology

IPPE attendees will be able to hear about Amlan technology, interact with Amlan experts, and even hold Amlans mineral in their hands at booth B5255.

Key Points: 
  • IPPE attendees will be able to hear about Amlan technology, interact with Amlan experts, and even hold Amlans mineral in their hands at booth B5255.
  • The global Amlan team invites IPPE attendees to learn more about the Amlan difference in bringing innovative solutions to improve the welfare and sustainability of food production while also ensuring optimum production efficiency.
  • During Almans educational TECHTalk presentations, renowned poultry industry experts will share new information on tackling poultry industry challenges.
  • Oil-DriCorporation of America doing business as Amlan International is a publiclytraded stock on the New York StockExchange (NYSE: ODC).

Your IndividualiTEA is the Key to $500 and a Year's Supply of Tea

Retrieved on: 
Tuesday, December 14, 2021
People, Sleep, TikTok, Bacteria, Weight loss, Awareness, Friends, Association, Flora (microbiology), Yan, Polyphenol, Microbiology, Inborn errors of metabolism, Trial, Tea, Research, Mechanical philosophy, Cardiovascular disease, Derbyshire, Immune system, IG, Obesity, Council, Multimedia, Degenerative disease, Twitter, Partnership, Gut–brain axis, Health, View, Dietary supplement, Coffee, Instagram

To celebrate every sip, the Tea Council of the USA is kicking off their sixth annual #IndividualiTEA Photo Sharing Sweepstakes .

Key Points: 
  • To celebrate every sip, the Tea Council of the USA is kicking off their sixth annual #IndividualiTEA Photo Sharing Sweepstakes .
  • Tell us how tea fits into your daily routine for a chance to win $500, a year's supply of tea and an at-home tea ritual starter kit.
  • When you center yourself around a cup of polyphenol-packed true tea black, green, white, oolong or dark your mind and body benefit.
  • Tea Compounds and the Gut Microbiome: Findings from Trials and Mechanistic Studies.Nutrients,11(10), 2364. https://doi.org/10.3390/nu11102364
    View original content to download multimedia: https://www.prnewswire.com/news-releases/your-individualitea-is-the-key-...